Preeclampsia, hypoxia, thrombosis, and inflammation
- PMID: 22175023
- PMCID: PMC3235807
- DOI: 10.1155/2012/374047
Preeclampsia, hypoxia, thrombosis, and inflammation
Abstract
Reductions in uteroplacental flow initiate a cascade of molecular effects leading to hypoxia, thrombosis, inflammation, and endothelial cell dysfunction resulting in untoward pregnancy outcomes. In this review, we detail these effects and their relationship to preeclampsia (PE) and intrauterine growth restriction (IUGR).
References
-
- Roccella EJ. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology. 2000;183(1):S1–S22. - PubMed
-
- ACOG Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstetrics and Gynecology. 2002;99:159–167. - PubMed
-
- Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. American Journal of Obstetrics and Gynecology. 2004;190(6):1520–1526. - PubMed
-
- Berg CJ, MacKay AP, Qin C, Callaghan WM. Overview of maternal morbidity during hospitalization for labor and delivery in the united states: 1993–1997 and 2001–2005. Obstetrics and Gynecology. 2009;113(5):1075–1081. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
